Peter F Ambros

6PUBLICATIONS
50CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)NeurogeneticsSemi- and unsupervised learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 28, 2023
Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial.

Tim Flaadt, Ruth L Ladenstein, Martin Ebinger

|Sep 10, 2021
Landscape of Bone Marrow Metastasis in Human Neuroblastoma Unraveled by Transcriptomics and Deep Multiplex Imaging.

Daria Lazic, Florian Kromp, Fikret Rifatbegovic

|Jun 21, 2021
Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study.

Alberto Garaventa, Ulrike Poetschger, Dominique Valteau-Couanet

|Jun 11, 2021
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1).

Angela Bellini, Ulrike Pötschger, Virginie Bernard

|Feb 05, 2021
Long-Term Outcome and Role of Biology within Risk-Adapted Treatment Strategies: The Austrian Neuroblastoma Trial A-NB94.

Stefan Fiedler, Inge M Ambros, Evgenia Glogova

|Aug 13, 2020
An annotated fluorescence image dataset for training nuclear segmentation methods.

Florian Kromp, Eva Bozsaky, Fikret Rifatbegovic

Pageof 1

Frequent Collaborators

3 joint publications

Ulrike Pötschger

3 joint publications

Ruth Lydia Ladenstein

3 joint publications

Sabine Taschner-Mandl

2 joint publications

Victoria Castel